• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Somerset`s Generics Travoprost Receives Approval in US

    FDA

    Ocular Therapeutix™ to Present at Two Investor Conferences

    GLOBENEWSWIRE

    Wilmington Eye: iDose TR For Ocular Hypertension, Open-Angle Glaucoma

    ACCESSWIRE

    Ocular Announces Positive Ph 2 PAXTRAVA Glaucoma Data at theASCRS

    GLOBENEWSWIRE

    Glaukos Receives Permanent J-code for iDose TR (travoprost intracameral implant)

    BUSINESSWIRE

    Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)

    BUSINESSWIRE

    Enforcement Report - Week of June 14, 2023

    FDA

    Enforcement Report - Week of April 13, 2022

    FDA

    Alembic Pharmaceuticals announces USFDA Approval for Travoprost

    PRESS RELEASE

    Alembic Pharmaceuticals Ltd`s Generic Travoprost Receives Approval in US

    FDA

    Apotex`s Generic Travoprost Receives Tentative Approval in US

    FDA

    Three Made in India drugs recalled in US: FDA

    DECCAN HERALD

    Ocular completes end-of-phase 2 review with FDA for OTX-TP for glaucoma

    PBR

    No quick fix seen for Novartis`s troubled Alcon unit

    REUTERS

    New Wave of Drugs Poised to Shake Up Glaucoma Treatment

    REUTERS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.